Loading chat...
MN SF3400
Bill
Status
2/20/2020
Primary Sponsor
Rich Draheim
Click for details
AI Summary
-
Pharmacy benefit managers and health carriers are prohibited from requiring or preferring specific pharmacies or providers for prescribing or dispensing reference biological products, biosimilar products, or interchangeable biological products.
-
If a pharmacy benefit manager or health carrier covers any one of these three product types, it must provide equivalent coverage for all three types.
-
Patients cannot be required to switch from a prescribed biological product to a different product with a higher retail price.
-
Defines "biosimilar product" as a biological product the FDA has licensed and determined to be biosimilar or therapeutically equivalent under federal law.
-
Requires medical assistance and MinnesotaCare drug coverage and reimbursement to comply with the biological products choice provisions.
Legislative Description
Pharmacy and provider choice related to prescribing and dispensing of biological products authorization
Last Action
Author added Klein
3/16/2020